The Korean clinical research center for end- stage renal disease study validates the association of hemoglobin and erythropoiesis-stimulating agent dose with mortality in hemodialysis patients

Clinical Research Center for End-Stage Renal Disease (CRC- ESRD) Investigators

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The Korean clinical research center for end- stage renal disease study validates the association of hemoglobin and erythropoiesis-stimulating agent dose with mortality in hemodialysis patients'. Together they form a unique fingerprint.

Medicine & Life Sciences